[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4966 followers Created: 2025-07-20 16:03:03 UTC 🦉 PCOS affects 5–6 million U.S. women. 35–80% are insulin resistant. No standard treatment exists; birth control, Metformin, and lifestyle changes address symptoms partially. GLP-1s offer new metabolic leverage. #PCOS #GLP1 $NVO $LLY $AZN $SNY $GSK XX engagements  **Related Topics** [manat](/topic/manat) [$gsk](/topic/$gsk) [$sny](/topic/$sny) [$lly](/topic/$lly) [women](/topic/women) [$nvo](/topic/$nvo) [stocks healthcare](/topic/stocks-healthcare) [eli lilly](/topic/eli-lilly) [Post Link](https://x.com/AponiaAnalytics/status/1946964079089733922)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4966 followers
Created: 2025-07-20 16:03:03 UTC
🦉 PCOS affects 5–6 million U.S. women. 35–80% are insulin resistant. No standard treatment exists; birth control, Metformin, and lifestyle changes address symptoms partially. GLP-1s offer new metabolic leverage.
#PCOS #GLP1 $NVO $LLY $AZN $SNY $GSK
XX engagements
Related Topics manat $gsk $sny $lly women $nvo stocks healthcare eli lilly
/post/tweet::1946964079089733922